People's Daily reporter Wang Wenjuan
A 50-year-old female patient presents to the hospital with recurrent chest tightness and angina. The cardiology department prescribed a routine cardiac coronary angiography, but the results showed that there was no significant stenosis of the three blood vessels of the heart; Further examination by nuclear medicine myocardial perfusion imaging did not reveal any significant defect in myocardial uptake. Finally, after further examination and analysis of blood flow quantification with the help of D-SPECT equipment, the patient was diagnosed with coronary microvascular dysfunction and coronary microcirculation disorder. After the diagnosis, the doctor adjusted the treatment plan in time and cooperated with lifestyle intervention to effectively improve the patient's recovery.
The key equipment supporting this accurate diagnosis is D-SPECT, the country's first domestic digital heart-specific single-photon device produced by Optical Pulse Medical. Ma Xin, general manager of Shanghai Guangmai Medical Technology Co., Ltd. (hereinafter referred to as "Guangmai Medical"), introduced that D-SPECT is a SPECT device focusing on cardiac examination, mainly used in myocardial perfusion imaging examination, which is not only simple, non-invasive and safe, but also shorter imaging time and higher image quality than traditional methods, which effectively improves the accuracy of diagnosis, and is currently a more reliable equipment for diagnosing myocardial ischemia of coronary heart disease.
2021年9月，光脈醫療中國總部落地上海臨港，入駐地產閔虹下屬閔行開發區臨港園區打造的“智芯源”載體。集生產、製造、研發為一體的光脈醫療，由此全面推進國產高端分子影像設備的當地語系化生產與規模化應用。
Why did Guangmai Medical choose to settle in "Zhixinyuan"? How does Lingang Park attract advanced medical equipment companies?
The park should be a good "shop second" and retain enterprises with services
A high-quality business environment is the key for enterprises to choose to settle down. Ma Xin said frankly that as a manufacturer of nuclear medical imaging equipment, Guangmai chose to purchase a comprehensive plant of more than 1000 square meters in Lingang Park, Minhang Development Zone, including 0 square meters of intelligent manufacturing space and 0 square meters of R&D office area. "From the beginning of the contact, the local government said that they are 'shop two' to serve the enterprise, to the site selection, to the purchase and decoration of the factory, I think the service awareness of this park is particularly good, and I experience a kind of equality and mutual assistance, and the park will consider how to solve the problem from the perspective of the enterprise. Even in the early stage when the plant has not yet been completed and the supporting facilities are not perfect, the park will still solve practical problems such as material supply and temporary resettlement for us. In the process of contact, we can always feel this sense of service, not only to assist in many businesses that we are not familiar with, but also to lend a helping hand in difficult times, which is very touching to everyone. ”
據瞭解，“智芯源”專案是臨港新片區“東方芯港”的重要組成部分，是地產閔虹回應《中國(上海)自由貿易試驗區臨港新片區總體方案》中提出的建立以關鍵核心技術為突破口的前沿產業集群規劃，所啟動的“積體電路+智能製造”產業綜合體專案，總建築面積近40萬平方米。
In the face of the growth of the regional market and the demand for the development of high-end molecular imaging equipment in China, Guangmai Medical will mainly carry out the R&D, production and sales of "single-photon tomography computer scanner" (hereinafter referred to as "SPECT") after entering "Zhixinyuan", realize the R&D and expansion of production capacity of high-end molecular imaging equipment, and help the field of nuclear medicine SPECT move to a new height.
Deeply cultivate molecular imaging technology to inject new vitality into the park
In the process of development, Optical Pulse Medical has continuously promoted technology research and development, and gradually grown into an influential enterprise in the field of international nuclear energy medical imaging, mastering a number of independent research and development of advanced technologies. Since its establishment, the company has focused on the research and development of digital molecular imaging equipment, and has continued to deepen its efforts in molecular imaging technology innovation.
Recently, the country's first domestic digital heart special single-photon device D-SPECT was put into use in Fuwai Hospital of the Chinese Academy of Medical Sciences, Ma Xin introduced: "Compared with the traditional SPECT, the digital heart machine in the patient to bear the radiation dose, on the basis of the examination cost does not increase, the examination time is greatly shortened, and the diagnosis results are more accurate, the diagnosis and treatment efficiency and the patient's sense of access to medical treatment to achieve double improvement." ”
It is understood that gated myocardial perfusion imaging (GMPI) is currently the only imaging examination technique that can evaluate myocardial perfusion and left ventricular function at the same time through a single examination. The non-invasive molecular imaging examination methods represented by the new D-SPECT cardiac molecular imaging equipment have important clinical value in the diagnosis and treatment of coronary heart disease, risk stratification, detection of viable myocardium, treatment decision-making, efficacy evaluation, prognosis evaluation and other heart diseases. GMPI is the most accurate and evidence-based non-invasive method for diagnosing ischemic coronary heart disease.
At the same time, the 360° full-loop VERITON-CT produced by Optical Pulse Medical is the world's first SPECT/CT using semiconductor technology detection, and the detection efficiency and resolution are increased by 0-0 times compared with traditional equipment. VERITON-CT uses a 0° full-field digital detector and an automatic retractable detection module to achieve the highest level of sensitivity and energy resolution in the industry. While greatly improving the clarity of clinical images, it also doubles the time of clinical examination and improves the diagnostic ability of the department. In addition, in the field of international advanced integration of nuclear diagnosis and treatment, VERITON-CT provides key technical support for tumor precision medicine by building an accurate quantitative analysis and dynamic treatment monitoring system in the field of new nuclear therapy, and effectively empowers the optimization and upgrading of personalized treatment plans.
"The two product lines produced by Optical Pulse Medical have been fully introduced into overseas technology and fully localized, and are included in the Shanghai New Excellent Drug and Medical Device Catalog, which is in line with the national trade-in priority localization procurement policy." Ma Xin said, "At present, there are more than 301 installed units in the world, including Brigham Hospital affiliated to Harvard University, Mayo Clinic, Yale University Hospital, Cleveland Clinic, Royal Southampton Hospital, Nancy Hospital in France, National Medical Center of Singapore, Osaka Hospital in Japan, Hong Kong Sanatorium & Hospital, Beijing 0 Hospital, Beijing Fuwai Hospital, Zhongshan Hospital Affiliated to Fudan University, Second Affiliated Hospital of Zhejiang University, etc., all of which have purchased the company's products and maintained long-term scientific research and academic cooperation." ”
"As the world's leading manufacturer of molecular imaging equipment, in the future, Lightpulse Medical will continue to deepen the field of medical imaging, continuously increase R&D investment, and strive to bring more advanced and efficient medical equipment to the market, contribute China's wisdom and strength to improve the level of global medical diagnosis, and let more patients benefit from the benefits brought by scientific and technological innovation." Ma Xin said.
Real estate Min Hong said that under the leadership of the Lingang New Area Management Committee and the real estate group, Minhong and its subsidiary Minlian Lingang Company will strive to be the first and take the lead in the development of new quality productivity, and promote the growth of emerging industries and the cultivation of future industries as a whole; We will continue to make service the core competitiveness of the industry, create clusters and ecological development, and let good projects come, retain and develop well.